Icepan-DSR Capsule is a combination pharmaceutical formulation containing Domperidone 10 mg and Pantoprazole 40 mg, designed to manage gastrointestinal disorders characterized by acid reflux and motility disturbances. Domperidone, a dopamine D2 receptor antagonist, facilitates gastric emptying and enhances gastrointestinal motility, thereby alleviating symptoms such as nausea, vomiting, and bloating. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme in the gastric parietal cells, providing effective relief from acid-related conditions including gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The synergistic action of these two agents in Icepan-DSR Capsule offers both symptomatic relief and addresses the underlying pathophysiology of acid reflux and delayed gastric emptying. This medication is typically prescribed for patients experiencing dyspepsia, GERD with associated motility issues, and other acid-peptic disorders where both acid suppression and prokinetic effects are beneficial. Icepan-DSR should be taken as directed by a healthcare professional, usually before meals, to optimize therapeutic outcomes. Caution is advised in patients with known hypersensitivity to either component, cardiac arrhythmias, or those on medications that prolong the QT interval. Regular monitoring and adherence to prescribed dosage are essential to minimize potential adverse effects and ensure efficacy.